LOGIN  |  REGISTER
Assertio
C4 Therapeutics

CareRx to Host Third Quarter 2025 Financial Results Conference Call on Tuesday, November 4, 2025 at 8:30 a.m. ET

October 24, 2025 | Last Trade: C$3.59 0.01 0.28

Toronto, Ontario--(Newsfile Corp. - October 24, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company") today announced it will host a conference call to discuss its third quarter 2025 financial results on Tuesday, November 4, 2025, at 8:30 a.m. Eastern Time (ET). The Company expects to report its third quarter 2025 financial results for the period ended September 30, 2025, after market close on Monday, November 3, 2025.

Telephone Dial-In Access Information

To dial direct and enter the call through an operator, dial 647-849-3320 or 1-833-752-4643. Please connect approximately 15 minutes prior to the beginning of the call to ensure participation. Those participating in the conference call by telephone can view the slide presentation by accessing the online webcast (see instructions below).

Webcast Access Information

A link to access the live webcast of the conference call, including the slide presentation, will be available on the Events and Presentations page of the Investors section of the Company's website (https://carerx.ca/presentations/) and can be accessed here. Please connect at least 15 minutes prior to the conference call.

The webcast with slide presentation will be archived for 90 days on the Events and Presentations page of the Investors section of the Company's web site (https://carerx.ca/presentations/).

About CareRx Corporation

CareRx is Canada's leading provider of pharmacy services to seniors living and other congregate care communities (long-term care homes, retirement homes, assisted living facilities and group homes). We are a national organization with a large network of pharmacy fulfillment centers strategically located across the country. This allows us to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. We use best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the highest levels of safety and adherence for individuals with complex medication regimens. We take an active role in working with our home operator partners to promote resident health, staff education, and medication system quality and efficiency.

For more information, visit www.carerx.ca or contact:

Neil Weber
Investor Relations
LodeRock Advisors
(647) 222-0574
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.loderockadvisors.com

Viking Therapeutics

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page